About this trial
The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population.
The main aims are:
1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population. 2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.
Eligibility criteria
Qualifiers
Adult patients part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
Patients with signed informed consent
Disqualifiers
Cognitive impairment
Patients unable to understand the oral and written study information in Swedish or English
Other severe disorder or terminal disease
Patients unable to provide an informed consent
Trial design
Treatments tested in this trial
- Not listed